Evidence map›Paper›PMID 38048049›Full record

ArticleChemical communications (Cambridge, England)2023

Engineered fluorogenic HaloTag ligands for turn-on labelling in live cells.

Bryan J Lampkin, Joshua A Kritzer

Open access · greenAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bryan J LampkinDepartment of Chemistry, Tufts University, 62 Talbot Rd, Medford, MA 02155, USA. joshua.kritzer@tufts.edu.ORCID http://orcid.org/0000-0002-8633-1227
Joshua A KritzerDepartment of Chemistry, Tufts University, 62 Talbot Rd, Medford, MA 02155, USA. joshua.kritzer@tufts.edu.ORCID http://orcid.org/0000-0003-2878-6781
Tufts University · US

Funding

Diversity Supplement for Imani McDonald - Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule TherapeuticsR35GM148407 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI Joshua A Kritzer · 2023 to 2026
$2.6M
Cell Penetration Profiling for BiotherapeuticsR01GM127585 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI KRITZER, JOSHUA A · 2018 to 2022
$1.6M
A Fluorogenic System for Measuring Cytosolic LocalizationF32GM139371 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI LAMPKIN, BRYAN J · 2021 to 2023
$210k
NIGMS NIH HHS F32 GM139371NIGMS NIH HHS R01 GM127585NIGMS NIH HHS R35 GM148407
6 · The paper itself

Abstract

Recent years have seen dramatic improvements in the design of organic fluorophores based on limiting non-radiative decay pathways. We sought to extend this understanding to benzothiadiazoles that have been used as turn-on fluorescent substrates for the self-labeling protein HaloTag. When conjugated to HaloTag, the benzothiadiazoles reside in a narrow tunnel that precludes twisted internal charge transfer, which allowed us to explore steric and electronic effects on other non-radiative decay pathways. By minimizing both non-radiative decay and nonspecific interactions with cellular components, we produced improved turn-on dyes with 136-fold increase in fluorescence over background in cells.

Indexed as

HydrolasesProteinsFluorescent DyesLigandsMicroscopy, FluorescenceFluorescent Dyeshaloalkane dehalogenaseHydrolasesLigandsProteins

Identifiers

PMID38048049
PMCPMC10835756
OpenAlexW4389126134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.